Psychometric validation of the Chinese Version of the stimulant relapse risk scale (SRRS) in patients with methamphetamine use disorder
- PMID: 38978076
- PMCID: PMC11232344
- DOI: 10.1186/s13011-024-00616-8
Psychometric validation of the Chinese Version of the stimulant relapse risk scale (SRRS) in patients with methamphetamine use disorder
Abstract
Background: Evaluating the risk of relapse is a pivotal step in the treatment of patients with methamphetamine use disorder (MUD). The 30-item Stimulant Relapse Risk Scale (SRRS) was originally developed in Japan to meet the demand. This study examined the reliability, validity, and factor structure of the Chinese version of the SRRS for patients with MUD.
Methods: 247 patients with MUD self-rated the Chinese version of the SRRS. Cronbach's alpha coefficients and inter-item correlation analysis were used to assess the internal consistency reliability. Construct validity was determined through confirmatory factor analysis (CFA), and concurrent validity was examined using the visual analogue scale (VAS) for drug craving and the severity of dependence scale (SDS). We followed the participants for 1 year and assessed the predictive validity based on the correlation of the scores of the Chinese version of the SRRS with the relapse rate within 3, 6, and 12 months of follow-up.
Results: CFA revealed satisfactory model fit estimates for the 22-item Chinese version of the SRRS that consisted of four subscales. The four-factored 22-item Chinese version of the SRRS had adequate internal consistency with Cronbach's alphas ranging from 0.76 to 0.92. The 22-item Chinese version of the SRRS scores were significantly correlated with the VAS and SDS scores as well as the relapse rate within 3, 6, and 12 months, indicating good concurrent and predictive validity of this scale. The receiver operating characteristic curve revealed a cutoff score of 40 could discriminate between participants with (SDS score ≥ 4) and without (SDS score < 4) methamphetamine dependence (area under the curve = 0.71, p < 0.01).
Conclusions: The 22-item Chinese version of the SRRS that consists of four subscales is a valid and reliable instrument to assess the relapse risk in patients with MUD.
Keywords: Instrument; Methamphetamine; Psychometric properties; SRRS; Validity.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11232344/bin/13011_2024_616_Fig1_HTML.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11232344/bin/13011_2024_616_Fig2_HTML.gif)
Similar articles
-
Development and validation of Tagalog versions of the Drug Abuse Screening Test-20 (DAST-20) and Stimulant Relapse Risk Scale (SRRS) for drug users in the Philippines.PLoS One. 2023 Jan 6;18(1):e0280047. doi: 10.1371/journal.pone.0280047. eCollection 2023. PLoS One. 2023. PMID: 36607996 Free PMC article.
-
Development and validation of the Stimulant Relapse Risk Scale for drug abusers in Japan.Drug Alcohol Depend. 2007 May 11;88(2-3):174-81. doi: 10.1016/j.drugalcdep.2006.10.005. Epub 2006 Nov 21. Drug Alcohol Depend. 2007. PMID: 17118576
-
Psychometric assessment of the Chinese version of the Problems and Needs in Palliative Care questionnaire-short version in advanced cancer patients.BMC Palliat Care. 2019 Aug 6;18(1):68. doi: 10.1186/s12904-019-0450-5. BMC Palliat Care. 2019. PMID: 31387575 Free PMC article.
-
Psychometric evaluation of the Chinese version of alcohol relapse risk scale (C-ARRS) in patients with alcohol use disorder.Alcohol. 2024 Jun 4;120:25-33. doi: 10.1016/j.alcohol.2024.05.003. Online ahead of print. Alcohol. 2024. PMID: 38843962
-
The Chinese version of the Perceived Stress Questionnaire: development and validation amongst medical students and workers.Health Qual Life Outcomes. 2020 Mar 13;18(1):70. doi: 10.1186/s12955-020-01307-1. Health Qual Life Outcomes. 2020. PMID: 32169070 Free PMC article.
References
-
- United Nations Office on Drugs and Crime. World drug report 2022: Global overview of drug demand and drug supply 2022 [ https://www.unodc.org/unodc/en/data-and-analysis/wdr-2022_booklet-2.html
-
- Stoneberg DM, Shukla RK, Magness MB. Global methamphetamine trends: an evolving problem. Int Crim Justice Rev. 2018;28(2):136–61. doi: 10.1177/1057567717730104. - DOI
-
- United Nations Office on Drugs and Crime. World drug report 2022: drug market trends cocaine amphetamine_type stimulants new psychoactive substances 2022 [Available from: www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2022.html
Publication types
MeSH terms
Substances
Grants and funding
- 109-2314-B-532-0041 and 110-2314-B-532-005-MY3/National Science and Technology Council
- 110-2314-B-715-013/National Science and Technology Council
- TPECH 11001-62-003 and 11101-62-029/Taipei City Government
- TPCH 110-61 and 111-56/Taipei City Hospital
- MMC-RD-110-1B-P011 and MMC-RD-111-1H-P007/MacKay Medical College
LinkOut - more resources
Full Text Sources
Medical